| Literature DB >> 34990923 |
Ashaka Patel1, Agnieszka Dzioba2, Paul Hong3, Murad Husein4, Julie Strychowsky5, Peng You6, Josee Paradis7, M E Graham8.
Abstract
BACKGROUND: The COVID-19 pandemic has shifted medical practice globally. The objective of this study was to examine the changes to the practice of pediatric otolaryngology internationally due to the COVID-19 pandemic and examine potential contributors.Entities:
Keywords: COVID-19; Disease incidence; Pediatric otolaryngology; Practice changes; Resident training; Social distancing
Mesh:
Year: 2022 PMID: 34990923 PMCID: PMC8720179 DOI: 10.1016/j.ijporl.2021.111021
Source DB: PubMed Journal: Int J Pediatr Otorhinolaryngol ISSN: 0165-5876 Impact factor: 1.675
Geographic distribution of respondents.
| Country | N (%) |
|---|---|
| United Kingdom | 10 (22) |
| Birmingham | |
| Bristol | |
| Cambridge | |
| Liverpool | |
| London | |
| Manchester | |
| Portsmouth | |
| Southampton | |
| Australia | 8 (18) |
| Brisbane | |
| Perth | |
| Sydney | |
| Canada | 8 (18) |
| Edmonton | |
| Halifax | |
| London | |
| Montreal | |
| Toronto | |
| Vancouver | |
| Winnipeg | |
| Ireland | 3 (7) |
| Dublin | |
| Malaysia | 3 (7) |
| Kuala Lumpur | |
| Kuching | |
| United States | 3 (7) |
| Cincinnati | |
| New York | |
| Salt Lake City | |
| Spain | 2 (4) |
| Barcelona | |
| Chile | 1 (2) |
| Santiago | |
| Columbia | 1 (2) |
| Bogota | |
| France | 1 (2) |
| Lille | |
| Israel | 1 (2) |
| Nahariya | |
| Kuwait | 1 (2) |
| Kuwait City | |
| South Africa | 1 (2) |
| Cape Town | |
| Thailand | 1 (2) |
| Chiang Mai | |
| Wales | 1 (2) |
| Cardiff |
Fig. 1Public health restrictions mandated during the pandemic when measures were most strict, average, and most lenient. Respondents were surveyed regarding community public health measures at different time points over the COVD-19 pandemic.
Pediatric otolaryngology conditions during the COVID-19 pandemic.
| Condition type | Condition | Decreased (%) | No Change (%) | Increased (%) | Frequency Category |
|---|---|---|---|---|---|
| Infectious or Inflammatory | Otitis media with effusion | 77.5 | 17.5 | 5.0 | Almost all decreased (>75%) |
| Acute otitis media | 84.2 | 10.5 | 5.3 | Almost all decreased (>75%) | |
| Acute Mastoiditis | 86.5 | 13.5 | 0.0 | Almost all decreased (>75%) | |
| Recurrent pharyngotonsillitis | 77.5 | 15.0 | 7.5 | Almost all decreased (>75%) | |
| Peritonsillar abscess | 77.8 | 19.4 | 2.8 | Almost all decreased (>75%) | |
| Intracranial complications of mastoiditis | 73.0 | 24.3 | 2.7 | Most decreased (50–74%) | |
| Otitis externa | 51.5 | 45.5 | 3.0 | Most decreased (50–74%) | |
| Recurrent acute sinusitis | 68.4 | 23.7 | 7.9 | Most decreased (50–74%) | |
| Orbital complications of sinusitis | 71.8 | 15.4 | 12.8 | Most decreased (50–74%) | |
| Chronic sinusitis | 57.9 | 36.8 | 5.3 | Most decreased (50–74%) | |
| Adenoid Hypertrophy | 51.4 | 40.5 | 8.1 | Most decreased (50–74%) | |
| Recurrent Croup | 64.9 | 29.7 | 5.4 | Most decreased (50–74%) | |
| Deep space neck abscesses | 55.3 | 34.2 | 10.5 | Most decreased (50–74%) | |
| Recurrent Pneumonia | 48.4 | 51.6 | 0.0 | No change in >50% | |
| Bacterial Tracheitis | 47.2 | 50.0 | 2.8 | No change in >50% | |
| Recurrent Respiratory Papillomatosis | 12.9 | 80.6 | 6.5 | No change in >50% | |
| Non-tuberculous neck abscesses | 20.6 | 70.6 | 8.8 | No change in >50% | |
| Cervical lymphadenitis/abscesses | 42.1 | 52.6 | 5.3 | No change in >50% | |
| Nasal Polyps | 26.9 | 65.4 | 7.7 | No change in >50% | |
| Turbinate hypertrophy | 34.4 | 53.1 | 12.5 | No change in >50% | |
| Allergic Rhinitis | 24.1 | 62.1 | 13.8 | No change in >50% | |
| Non-allergic rhinitis | 22.2 | 70.4 | 7.4 | No change in >50% | |
| Mass/malignancy | Thyroid masses | 3.8 | 80.3 | 15.4 | No change in >50% |
| Head and neck malignancy | 7.4 | 74.1 | 18.5 | No change in >50% | |
| Neurologic or Functional issue | Velopharyngeal insufficiency | 8.3 | 87.5 | 4.2 | No change in >50% |
| Dysphagia | 3.1 | 81.3 | 15.6 | No change in >50% | |
| Drooling | 10.0 | 76.7 | 13.3 | No change in >50% | |
| Traumatic | Cholesteatoma – Acquired | 26.1 | 65.2 | 8.7 | No change in >50% |
| Epistaxis | 12.5 | 52.6 | 25.0 | No change in >50% | |
| Nasal fracture/trauma | 26.5 | 58.8 | 14.7 | No change in >50% | |
| Congenital anomaly | Cholesteatoma – Congenital | 16.7 | 77.8 | 5.6 | No change in >50% |
| Congenital anomalies ear | 16.7 | 83.3 | 0.0 | No change in >50% | |
| Choanal Atresia | 7.4 | 88.9 | 3.7 | No change in >50% | |
| Other congenital anomalies of the nose | 7.7 | 84.6 | 7.7 | No change in >50% | |
| Ankyloglossia | 15.4 | 76.9 | 7.7 | No change in >50% | |
| Unilateral vocal fold paralysis | 8.6 | 85.7 | 5.7 | No change in >50% | |
| BVFP | 3.1 | 93.8 | 3.1 | No change in >50% | |
| Laryngeal cleft | 3.0 | 84.8 | 12.1 | No change in >50% | |
| Congenital neck cysts | 11.1 | 83.3 | 5.6 | No change in >50% | |
| Lymphovascular anomalies | 6.3 | 87.5 | 6.3 | No change in >50% | |
| Foreign body | Foreign body ear | 20.0 | 46.7 | 33.3 | Even split |
| Foreign body nose | 14.7 | 50.0 | 35.3 | No change in >50% | |
| Foreign body airway | 11.8 | 64.7 | 23.5 | No change in >50% | |
| Other | TM Perforation | 46.7 | 53.3 | 0.0 | No change in >50% |
| Hearing loss | 30.0 | 60.0 | 10.0 | No change in >50% | |
| Septal Deviation | 18.5 | 77.8 | 3.7 | No change in >50% | |
| Obstructive sleep apnea/sleep-disordered breathing | 42.1 | 34.2 | 23.7 | Even split | |
| Ranula/Salivary gland problem | 19.4 | 74.2 | 6.5 | No change in >50% | |
| Intensive care unit airway consults | 33.3 | 47.2 | 19.4 | Even split | |
| Laryngomalacia | 14.3 | 62.9 | 22.9 | No change in >50% | |
| Hoarseness | 12.1 | 81.8 | 6.1 | No change in >50% | |
| Subglottic Stenosis | 17.1 | 71.4 | 11.4 | No change in >50% | |
| Acute airway obstruction requiring intubation | 25.0 | 66.7 | 8.3 | No change in >50% |
Fig. 2Changes in Disease Incidence for Pediatric Otolaryngology Conditions. All surveyed conditions were organized by changes in frequency observed over the COVID-19 pandemic.
Fig. 3Referral pattern changes of infectious/inflammatory conditions under average restrictions. Four statistically significant conditions decreased over the pandemic and the observed changes over the majority of the pandemic under average restrictions are presented.
Fig. 4Changes in Virtual Care Delivery. Respondents assessed their use of virtual care prior to and at the height of the pandemic. Anticipated future use of virtual care was also recorded.